151 related articles for article (PubMed ID: 2450153)
21. Structural and functional analysis of the S1 subunit of pertussis toxin using synthetic peptides.
Chong P; Sydor M; Wu E; Zobrist G; Boux H; Klein M
Mol Immunol; 1991 Mar; 28(3):239-45. PubMed ID: 2017195
[TBL] [Abstract][Full Text] [Related]
22. Induction of polyclonal antibodies to the S1 subunit of pertussis toxin by synthetic peptides coupled to PPD: effect of conjugation method, adjuvant, priming and animal species.
Ibsen PH; Holm A; Raaschou-Nielsen M; Petersen JW; Capiau C; Heron I
APMIS; 1992 Feb; 100(2):159-69. PubMed ID: 1554491
[TBL] [Abstract][Full Text] [Related]
23. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
[TBL] [Abstract][Full Text] [Related]
24. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
25. The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis.
Fiett J; Letowska I; Gniadkowski M; Hryniewicz W
J Microbiol Methods; 2003 Dec; 55(3):651-66. PubMed ID: 14607408
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.
Schmidt MA; Schmidt W
Infect Immun; 1989 Dec; 57(12):3828-33. PubMed ID: 2478479
[TBL] [Abstract][Full Text] [Related]
27. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
[TBL] [Abstract][Full Text] [Related]
28. Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin.
Petersen JW; Holm A; Ibsen PH; Hasløv K; Heron I
Infect Immun; 1993 Jan; 61(1):56-63. PubMed ID: 7678102
[TBL] [Abstract][Full Text] [Related]
29. Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.
Schmidt MA; Raupach B; Szulczynski M; Marzillier J
Infect Immun; 1991 Apr; 59(4):1402-8. PubMed ID: 1706321
[TBL] [Abstract][Full Text] [Related]
30. Agglutinogens and fimbriae of Bordetella pertussis.
Ashworth LA; Robinson A; Funnell S; Gorringe AR; Irons LI; Seabrook RN
Tokai J Exp Clin Med; 1988; 13 Suppl():203-10. PubMed ID: 2908520
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera.
Arciniega JL; Hewlett EL; Edwards KM; Burns DL
FEMS Immunol Med Microbiol; 1993 Apr; 6(4):325-30. PubMed ID: 8499896
[TBL] [Abstract][Full Text] [Related]
32. Dissecting human T cell responses against Bordetella species.
De Magistris MT; Romano M; Nuti S; Rappuoli R; Tagliabue A
J Exp Med; 1988 Oct; 168(4):1351-62. PubMed ID: 2902185
[TBL] [Abstract][Full Text] [Related]
33. Recognition of pertussis toxin by antibodies to synthetic peptides.
Seabrook RN; Robinson A; Sharma RP; Irons LI; Ashworth LA; Price CP; Atkinson T
Mol Immunol; 1990 Aug; 27(8):777-85. PubMed ID: 2402246
[TBL] [Abstract][Full Text] [Related]
34. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.
Halperin SA; Issekutz TB; Kasina A
J Infect Dis; 1991 Feb; 163(2):355-61. PubMed ID: 1703192
[TBL] [Abstract][Full Text] [Related]
35. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis.
Arciniega JL; Hewlett EL; Johnson FD; Deforest A; Wassilak SG; Onorato IM; Manclark CR; Burns DL
J Infect Dis; 1991 Jan; 163(1):135-42. PubMed ID: 1984460
[TBL] [Abstract][Full Text] [Related]
36. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
Cyr T; Menzies AJ; Calver J; Whitehouse LW
Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies against the enzymatic subunit of both pertussis and cholera toxins.
Kenimer JG; Probst PG; Karpas AB; Burns DL; Kaslow HR
Dev Biol Stand; 1991; 73():133-41. PubMed ID: 1778307
[TBL] [Abstract][Full Text] [Related]
38. Engineering bacterial toxin for the development of new vaccine against pertussis.
Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R
Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870
[TBL] [Abstract][Full Text] [Related]
39. Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay.
Mertsola J; Ruuskanen O; Kuronen T; Meurman O; Viljanen MK
J Infect Dis; 1990 May; 161(5):966-71. PubMed ID: 2324547
[TBL] [Abstract][Full Text] [Related]
40. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
Sato H; Sato Y
Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
